ACCESS Newswire

ORB Innovations Limited

Share
ORB Innovations Acquired by Glidewell (U.S.) for Development of Smart Oral Appliances Technology

U.K. start-up expands the reach of its revolutionary performance and wellness tracking technology via partnership with leading dental laboratory

LONDON, UK / ACCESSWIRE / May 24, 2023 / ORB Innovations Limited, a U.K. start-up that has developed a unique technology platform to measure physiological parameters such as heart rate, as well as biomechanics such as head impacts, has agreed to be acquired by California-based Glidewell, a global leader in custom dental solutions.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
ORB Innovations Acquired by Glidewell (U.S.) for Development of Smart Oral Appliances Technology
U.K. start-up expands the reach of its revolutionary performance and wellness tracking technology to consumers in the U.S.

The ORB technology platform is effectively the world's only fitness tracker wearable in the mouth. In some sports, it is also the only wearable that can be worn during competitive activities.

Robert Paterson, CEO and cofounder of ORB Innovations, said, "We are thrilled to join the Glidewell family. As one of the largest dental companies in the world, with a 50-year track record of pioneering new technology, we feel we have found a natural home. The acquisition will allow us to accelerate the launch of our unique platform in the U.S. and to increase the pace of our research and development in other areas. Together, ORB Innovations and Glidewell will bring to market a whole range of smart oral products that will provide flexible new options for health-conscious consumers."

Glidewell has a formidable record of technological innovation since its founding in 1970, but this acquisition marks the first investment in smart dental products in its expansive portfolio.

Glidewell CEO Stephenie Goddard said, "We see the platform the ORB team has developed as an exciting evolution for the sports market. And it's easy to envision application in other wellness-related areas, in line with Glidewell's mission to bring innovative solutions to dental practitioners and their patients all over the world."

Electrical engineers, software developers, sports and data scientists, and other technology enthusiasts in the U.K. are encouraged to visit www.orbinnovations.com to keep abreast of emerging employment opportunities.

Contact Information

Robert Paterson
CEO & Co-Founder
rob@orbinnovations.com
+447917771036

SOURCE: ORB Innovations

To view this piece of content from stats.newswire.com, please give your consent at the top of this page.

View source version on accesswire.com:
https://www.accesswire.com/756881/ORB-Innovations-Acquired-by-Glidewell-US-for-Development-of-Smart-Oral-Appliances-Technology

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

Global Sports Brand U.S. Polo Assn. Announced as Official Jersey and Apparel Sponsor for the Legendary Snow Polo World Cup St. Moritz13.1.2026 13:00:00 CET | Press release

WEST PALM BEACH, FL AND ST. MORITZ, SWITZERLAND / ACCESS Newswire / January 13, 2026 / U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), will make its debut as the Official Jersey and Apparel Sponsor of the 41stSnow Polo World Cup St. Moritz, taking place January 23-25, 2026, on the iconic frozen lake of St. Moritz. U.S. Polo Assn.'s inaugural partnership with the world's most prestigious and legendary snow polo tournament underscores the brand's authentic ties to the game and its continued commitment to supporting polo around the world.Photo Caption: Snow Polo World Cup St. Moritz, with Official Jersey and Apparel Sponsor, U.S. Polo Assn. Photo Credit: Christian Sommer Snow Polo World Cup St. Moritz 2026 is already shaping up to be a record-breaking year, with unprecedented demand for tickets, elite international players, and global attention focused on one of the world's most high-profile polo tournaments played on snow. This event will see more

Clean Air Metals Announces 2026 Strategic Objectives in Historically Strong PGE and Copper Markets13.1.2026 01:10:00 CET | Press release

THUNDER BAY, ON / ACCESS Newswire / January 12, 2026 / Clean Air Metals Inc. ("Clean Air Metals" or the "Company") (TSXV:AIR)(FRA:CKU0(OTCQB:CLRMF) is pleased to provide an overview of its 2026 objectives and highlights of 2025, for its 100%-owned Thunder Bay North ("TBN") Critical Minerals Project in Northwestern Ontario. Critical Project Advancement Objectives Spot prices for platinum, copper and palladium have appreciated by 70% (1000 $/oz), 25% (1.20 $/lb) and 50% 624($/oz) respectively versus study prices, since the results of the Preliminary Economic Assessment (PEA) were announced in the October 9th release. Using the financial model published in the PEA and applying current spot metal prices (as of January 6th), the TBN project shows a $708M1 NPV8 and a pre-tax IRR of 100% (post-tax NPV8 = $494M1 and IRR = 84%).This is a significant improvement in the project outlook in comparison to the PEA results that featured a $219.4M2 pre-tax NPV8 and a pre-tax IRR of 39%. This year, cons

Germany Buys Eight MQ-9B SeaGuardian(R) RPA Through NSPA12.1.2026 20:00:00 CET | Press release

NSPA Supports NATO Countries in the Acquisition and Sustainment of GA-ASI's Advanced Multi-Domain RPA SAN DIEGO, CALIFORNIA / ACCESS Newswire / January 12, 2026 / Germany's Federal Office of Bundeswehr Equipment, Information Technology and In-Service Support and the NATO Support and Procurement Agency (NSPA) have announced the procurement of eight MQ-9B SeaGuardian® Remotely Piloted Aircraft (RPA) from General Atomics Aeronautical Systems, Inc. (GA-ASI). The program includes four Certifiable Ground Control Stations. First delivery is expected in 2028. Germany joins a growing list of NATO countries that have selected GA-ASI's advanced MQ-9B RPA for its multi-domain capabilities with exceptionally long range and endurance. The platform provides pole-to-pole satellite control and de-icing capabilities to enable missions in cold climates. SeaGuardian features two multi-mode surface-search radars that deliver wide-area maritime surveillance, with an option to add Anti-Submarine Warfare capa

Datavault AI Announces Target to Expand its AI Driven Data Monetization Network to Over 100 Cities Across the Contiguous United States, Starting in the Second Half of 2026 with Corresponding 2027 Revenue Target12.1.2026 14:05:00 CET | Press release

Datavault AI expects to have a fully operational network with over 100 nodes across 33 cities nationwide, generating revenue in the second half of 2026. Target revenue for this project is $400 to $500 million, thereby supporting the $200 million revenue guidance for 2026. With the full deployment of Datavault AI's nodes across 100+ cities throughout the United States, the 2027 revenue target is $2.0 to $3.0 billion for 2027. New York and Philadelphia edge network activation positions Datavault AI to potentially capture a significant share of the insurance and financial sectors, the healthcare industry, and enterprise opportunities. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in AI-driven data valuation, monetization, credentialing, and digital engagement technologies, today highlighted the strategic importance of its New York and Philadelphia edge network deployment with Available Infrastructure's SanQtum AI platform. This

OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC12.1.2026 13:00:00 CET | Press release

Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC. Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also receive royalties based on a tiered percentage of annual net sales. While the detailed financial terms are not disclosed in accordance with the confidentiality provisions, the overall deal economics are broadly comparable to those of recent similar licensing transactions in the market. TegMine will obtain the exclusive global rights to develop and commercialize the ADC under the license agreemen

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye